Skip navigation
Agenda

Copay Accumulators • Benefit Design • Coupons & Discounts • Contracts & Rebates • Digital Disruptions

April 1-3, 2020
  • San Francisco, CA

Agenda

Want more agenda details? Download the brochure.

DAY ONE WEDNESDAY, APRIL 1, 2020

7:30

Registration and Continental Breakfast

Pricing Pressures, Policy Updates and Formulary Trends

8:30

Chairman’s Welcome and Opening Remarks

Chris Dowd
Executive Vice President, Market and Product Development
ConnectiveRx

8:45

STATE OF THE INDUSTRY
Navigate Evolving Healthcare Regulations and Proposals Amidst a
Shifting Landscape

Alyssa Palisi
Professional Staff Member
House Committee on Ways and Means (Invited)

9:30

PARTNERSHIP PAVILION
Navigating the Future of Pharma, PBM and Payer Relationships

MODERATOR:

Chris Dowd
Executive Vice President, Market and Product Development
ConnectiveRx

CONVERSATION CONTRIBUTORS:

George Keefe
Vice President and Head, Market Access
Teva Pharmaceuticals

Michael DiFiore
Head, Market Access
Sunovion Pharmaceuticals

10:30

Networking and Refreshment Break

11:00

PBM Insights — Advancements in Formulary Design and Management

Speaker TBA

12:00

Networking Luncheon

1:15

Employer Perspective Fireside Chat

Lauren Vela, MBA
Senior Director, Member Value
Pacific Business Group on Health

2:15

Assess the Landscape for Prior Authorization and Reimbursement Support — Reexamining the Roles of the Manufacturer and the Pharmacy

David Kowalsky
Director, Market Access and Patient Services
EyePoint Pharmaceuticals

3:30

CHOOSE BETWEEN TWO CONCURRENT WORKSHOPS (A-B)

A Keeping Up with Copay Industry Trends — What’s What and How Does It All Work

This session provides resources and foundational knowledge on copay program principles and strategies, as well as current industry trends and challenges on the horizon.

Clay Tucker
Vice President, New Business Development — Western US
ConnectiveRx

B Access and Reimbursement Executive Exchange*

During this advanced session, benchmark with key industry directors and executives on challenges facing the industry amid shifting market dynamics. Driven by attendees, take time to collaborate with industry counterparts, ensure operational alignments and brainstorm strategic solutions to key initiatives that are impacting the future of access and reimbursement.

Chris Dowd
Executive Vice President,
Market and Product Development
ConnectiveRx

*CBI reserves the right to qualify participants for this session. Participants must be Director level or above and currently be employed by a life sciences manufacturer.

5:00

Close of Day One

COCKTAIL RECEPTION immediately following the final session Hosted by:

DAY TWO THURSDAY, APRIL 2, 2020

8:00

Breakfast Hosted by:

8:30

Chairperson’s Review of Day One

Chris Dowd
Executive Vice President, Market and Product Development
ConnectiveRx

Copay, Coupons and Accumulators

8:45

PATIENT SPOTLIGHT
An Inside Look at the Patient Experience and Real-World Access Challenges

Jenn McNary
Advocacy and Outreach Director
Beauhawks

9:30

Specialty Spotlight — Overcome Formulary, Coupon, Copay and Access Challenges

Ticia Cawley
Vice President, Specialty Programs
ConnectiveRx

Katrina Cooper, PharmD
Clinical Specialty Pharmacist
Vanderbilt Medical Center

10:30

Networking and Refreshment Break Hosted by:

11:00

Affordability First — Leverage Digital Engagements to Drive Affordability

Bob Raffo
President & CEO
FirstView

12:00

Networking Luncheon

1:15

CHOOSE FROM THREE TAILORED TRACKS (1-3)

TRACK 1 Access and Affordability

I. Look Beyond Free Drug Programs — Patient Support Models

II. Implement Performance Measurements to Justify the Cost of Copay Programs

TRACK LEADERS:

Brent Schwartz
Executive Director, Reimbursement – U.S. Eye Care
Allergan

Gerard Rivera, PharmD
CEO
Rx Experts (Subsidiary of Pacific Pharmacy Group)

TRACK 2 Rebates and Contracting

I. Explore Point-of-Sale Rebates and Discounts

II. Explore Innovative Pricing and Contracting Models —
Outcomes- Based Contracting, Long-Term Plans and Value-Based Pricing

TRACK LEADER:

Kim Gwiazdzinski
former Assistant Vice President Trade Relations, Value and Outcomes Contracting
Prime Therapeutics

TRACK 3 Strategic Launch Planning

I. Brand Strategy Guide for Pre-Commercialization Planning and Understand Market Access Impact to Propel Launch

II. Marketing in the 21st Century

TRACK LEADER:

Donna Situ
Executive Director
Portola Pharmaceuticals

3:30

Networking and Refreshment Break

4:00

Copay Accumulator Programs Intensive

As the adoption of copay accumulators and maximizers expand, so does the need for pharmaceutical manufacturers to ensure a comprehensive understanding of the impact to the commercially insured patient population. In this interactive intensive, unravel program complexities and navigate the impact of this cost-shifting benefit design.

Kevin O’Meara
Subject Matter Expert, Affordability & Accumulator Strategies
ConnectiveRx

5:00

Close of Day Two

Networking, Wine and Cheese Reception immediately following the final session on day two

DAY THREE FRIDAY, APRIL 23, 2020

8:00

Continental Breakfast

8:00

Chairman’s Review of Day Two

Chris Dowd
Executive Vice President, Market and Product Development
ConnectiveRx

Innovation and Digital Disruptions

8:45

Identify Disruptions in Market Access —
Major Market Mergers, Joint Ventures and Emerging Digital Innovators

Michael DiFiore
Head, Market Access
Sunovion Pharmaceuticals

9:30

Car-T/Cell and Gene Therapy Formulary Design —
How to Find Value and Pay for Curative Therapies

Lauren Sullivan
Member
Epstein Becker Green

10:15

Networking and Refreshment Break

10:45

TECH TALK
Leverage Digital Therapeutics and Mobile Health to Drive Efficiencies in the HealthCare Ecosystem

Andy Molnar
Senior Director, Market Access
Cognoa

12:00

Close of Conference

Agenda

Want more agenda details? Download the brochure.

Want more agenda details? Download the brochure.

DAY ONE WEDNESDAY, APRIL 1, 2020

7:30

Registration and Continental Breakfast

Pricing Pressures, Policy Updates and Formulary Trends

8:30

Chairman’s Welcome and Opening Remarks

Chris Dowd
Executive Vice President, Market and Product Development
ConnectiveRx

8:45

STATE OF THE INDUSTRY
Navigate Evolving Healthcare Regulations and Proposals Amidst a
Shifting Landscape

Alyssa Palisi
Professional Staff Member
House Committee on Ways and Means (Invited)

9:30

PARTNERSHIP PAVILION
Navigating the Future of Pharma, PBM and Payer Relationships

MODERATOR:

Chris Dowd
Executive Vice President, Market and Product Development
ConnectiveRx

CONVERSATION CONTRIBUTORS:

George Keefe
Vice President and Head, Market Access
Teva Pharmaceuticals

Michael DiFiore
Head, Market Access
Sunovion Pharmaceuticals

10:30

Networking and Refreshment Break

11:00

PBM Insights — Advancements in Formulary Design and Management

Speaker TBA

12:00

Networking Luncheon

1:15

Employer Perspective Fireside Chat

Lauren Vela, MBA
Senior Director, Member Value
Pacific Business Group on Health

2:15

Assess the Landscape for Prior Authorization and Reimbursement Support — Reexamining the Roles of the Manufacturer and the Pharmacy

David Kowalsky
Director, Market Access and Patient Services
EyePoint Pharmaceuticals

3:30

CHOOSE BETWEEN TWO CONCURRENT WORKSHOPS (A-B)

A Keeping Up with Copay Industry Trends — What’s What and How Does It All Work

This session provides resources and foundational knowledge on copay program principles and strategies, as well as current industry trends and challenges on the horizon.

Clay Tucker
Vice President, New Business Development — Western US
ConnectiveRx

B Access and Reimbursement Executive Exchange*

During this advanced session, benchmark with key industry directors and executives on challenges facing the industry amid shifting market dynamics. Driven by attendees, take time to collaborate with industry counterparts, ensure operational alignments and brainstorm strategic solutions to key initiatives that are impacting the future of access and reimbursement.

Chris Dowd
Executive Vice President,
Market and Product Development
ConnectiveRx

*CBI reserves the right to qualify participants for this session. Participants must be Director level or above and currently be employed by a life sciences manufacturer.

5:00

Close of Day One

COCKTAIL RECEPTION immediately following the final session Hosted by:

DAY TWO THURSDAY, APRIL 2, 2020

8:00

Breakfast Hosted by:

8:30

Chairperson’s Review of Day One

Chris Dowd
Executive Vice President, Market and Product Development
ConnectiveRx

Copay, Coupons and Accumulators

8:45

PATIENT SPOTLIGHT
An Inside Look at the Patient Experience and Real-World Access Challenges

Jenn McNary
Advocacy and Outreach Director
Beauhawks

9:30

Specialty Spotlight — Overcome Formulary, Coupon, Copay and Access Challenges

Ticia Cawley
Vice President, Specialty Programs
ConnectiveRx

Katrina Cooper, PharmD
Clinical Specialty Pharmacist
Vanderbilt Medical Center

10:30

Networking and Refreshment Break Hosted by:

11:00

Affordability First — Leverage Digital Engagements to Drive Affordability

Bob Raffo
President & CEO
FirstView

12:00

Networking Luncheon

1:15

CHOOSE FROM THREE TAILORED TRACKS (1-3)

TRACK 1 Access and Affordability

I. Look Beyond Free Drug Programs — Patient Support Models

II. Implement Performance Measurements to Justify the Cost of Copay Programs

TRACK LEADERS:

Brent Schwartz
Executive Director, Reimbursement – U.S. Eye Care
Allergan

Gerard Rivera, PharmD
CEO
Rx Experts (Subsidiary of Pacific Pharmacy Group)

TRACK 2 Rebates and Contracting

I. Explore Point-of-Sale Rebates and Discounts

II. Explore Innovative Pricing and Contracting Models —
Outcomes- Based Contracting, Long-Term Plans and Value-Based Pricing

TRACK LEADER:

Kim Gwiazdzinski
former Assistant Vice President Trade Relations, Value and Outcomes Contracting
Prime Therapeutics

TRACK 3 Strategic Launch Planning

I. Brand Strategy Guide for Pre-Commercialization Planning and Understand Market Access Impact to Propel Launch

II. Marketing in the 21st Century

TRACK LEADER:

Donna Situ
Executive Director
Portola Pharmaceuticals

3:30

Networking and Refreshment Break

4:00

Copay Accumulator Programs Intensive

As the adoption of copay accumulators and maximizers expand, so does the need for pharmaceutical manufacturers to ensure a comprehensive understanding of the impact to the commercially insured patient population. In this interactive intensive, unravel program complexities and navigate the impact of this cost-shifting benefit design.

Kevin O’Meara
Subject Matter Expert, Affordability & Accumulator Strategies
ConnectiveRx

5:00

Close of Day Two

Networking, Wine and Cheese Reception immediately following the final session on day two

DAY THREE FRIDAY, APRIL 23, 2020

8:00

Continental Breakfast

8:00

Chairman’s Review of Day Two

Chris Dowd
Executive Vice President, Market and Product Development
ConnectiveRx

Innovation and Digital Disruptions

8:45

Identify Disruptions in Market Access —
Major Market Mergers, Joint Ventures and Emerging Digital Innovators

Michael DiFiore
Head, Market Access
Sunovion Pharmaceuticals

9:30

Car-T/Cell and Gene Therapy Formulary Design —
How to Find Value and Pay for Curative Therapies

Lauren Sullivan
Member
Epstein Becker Green

10:15

Networking and Refreshment Break

10:45

TECH TALK
Leverage Digital Therapeutics and Mobile Health to Drive Efficiencies in the HealthCare Ecosystem

Andy Molnar
Senior Director, Market Access
Cognoa

12:00

Close of Conference